Einstein in the News | U.S./Global

STAT interviews John Condeelis, Ph.D., about his role in a recent study that linked preoperative chemotherapy with activating the microenvironment of metastasis in breast cancer. Dr. Condeelis is professor and co-chair of anatomy and structural biology and co-director of the Gruss Lipper Biophotonics Center, and the Judith and Burton P. Resnick Chair in Translational Research at Einstein. (Monday, July 10, 2017)

More coverage on Dr. Condeelis | Dr. Condeelis' Profile


The New York Times interviews Gil Atzmon, Ph.D., and Nir Barzilai, M.D., about their study linking longevity with a common genetic mutation in men. Dr. Atzmon is associate professor of medicine and of genetics. Dr. Barzilai is the Ingeborg and Ira Leon Rennert Chair of Aging Research and director of the Institute for Aging Research at Einstein. (Monday, June 19, 2017)

More coverage on this story | More coverage on Dr. Atzmon | More coverage on Dr. Barzilai | Dr. Atzmon's Profile | Dr. Barzilai's Profile


Newsweek features Lauren Flicker, J.D., M.B.E., in a video and article on the ethics of developing a blood test to detect autism. Ms. Flicker is associate director of the Montefiore Einstein Center for Bioethics and assistant professor of epidemiology & population health at Einstein. (Thursday, June 15, 2017)

More coverage on Dr. Flicker | Dr. Flicker's Profile


NIH Research Matters features research led by Kartik Chandran, Ph.D., which found human antibodies that are effective against all major disease-causing ebolaviruses. Dr. Chandran is professor of microbiology & immunology and the Harold and Muriel Block Faculty Scholar in Virology. (Friday, June 09, 2017)

More coverage on Dr. Chandran | Dr. Chandran's Profile


The Washington Post quotes Simon Rego, Psy.D., on the surprising benefits of worrying. Dr. Rego is associate professor of clinical psychiatry and behavioral sciences at Einstein and chief psychologist at Montefiore Health System. (Wednesday, May 17, 2017)

More coverage on Dr. Rego | Dr. Rego's Profile


VICE interviews Sofiya Milman, M.D., on the link between genetics and longevity. Dr. Milman is assistant professor of medicine. (Monday, May 01, 2017)

Dr. Milman's Profile


The Atlantic interviews Eric Hollander, M.D., on a new study suggesting a link between autism and addiction. Dr. Hollander is a clinical professor of psychiatry and behavioral sciences at Einstein and director of the Autism and Obsessive Compulsive Spectrum Program at Montefiore Health System and Einstein. (Tuesday, March 21, 2017)

More coverage on Dr. Hollander | Dr. Hollander's Profile


Nature interviews Zev Williams, M.D., Ph.D., about his placental miRNA research, which he hopes will lead to an early-warning test for pre-eclampsia. Dr. Williams is assistant professor of obstetrics & gynecology and women's health and of genetics at Einstein and director of the Program for Early and Recurrent Pregnancy Loss (PEARL) at Einstein and Montefiore Health System. (Thursday, February 23, 2017)

Dr. Williams' Profile


ASCO Post interviews Joseph Sparano, M.D., about the clinical trial he is conducting, which uses a test developed by John Condeelis, Ph.D., that predicts the likelihood of metastasis in certain forms of breast cancer. Dr. Sparano is vice chairman of medical oncology at Montefiore Einstein Center for Cancer Care, professor of medicine and of obstetrics and gynecology & women's health at Albert Einstein College of Medicine and associate director of clinical research at the NCI-designated Albert Einstein Cancer Center. (Thursday, December 22, 2016)

More coverage on Dr. Sparano | Dr. Sparano's Profile


The New York Times interviews Jan Vijg, Ph.D., about research on the first attempt to reverse aging by partially reprogramming the genome in mice. Dr. Vijg is professor and chair of genetics, the Lola and Saul Kramer Chair in Molecular Genetics, and professor of ophthalmology & visual sciences at Einstein. (Thursday, December 22, 2016)

More coverage on Dr. Vijg | Dr. Vijg's Profile


Scientific American interviews Steven Sparr, M.D., about amusia, the inability to recognize musical tones or to reproduce them, which strikes many stroke victims. Dr. Sparr is professor in the Saul R. Korey Department of Neurology at Einstein and director of the neurovascular laboratory and of neurorehabilitation at the Stern Stroke Center at Montefiore. (Thursday, November 03, 2016)

More coverage on Dr. Sparr | Dr. Sparr's Profile


New York Times interviews Ana Maria Cuervo, M.D., Ph.D., about the scientist awarded the Nobel Prize for his discoveries on how cells recycle, known as autophagy. Dr. Cuervo is a leader in this field of research, focusing on chaperone-mediated autophagy. Dr. Cuervo is professor of developmental and molecular biology, of anatomy and structural biology, and of medicine, co-director of the Institute for Aging Research, and holds the Robert and Renée Belfer Chair for the Study of Neurodegenerative Diseases at Einstein. (Wednesday, October 05, 2016)

More coverage on this story | More coverage on Dr. Cuervo | Dr. Cuervo's Profile


Scientific American quotes Peter Belamarich, M.D., and cites his research that found health claims made by infant formula manufacturers are not supported by evidence. In response to his report, which was published in Clinical Pediatrics in 2015, the Food and Drug Administration now suggests that manufacturers conduct clinical trials to prove their claims.  Dr. Belamarich is associate professor and chief of general pediatrics at Einstein and vice-chair for affiliate and network relations at the Children’s Hospital at Montefiore. (Monday, September 12, 2016)

More coverage on this story | Dr. Belamarich's Profile


The Huffington Post quotes Sylvia Wassertheil-Smoller, Ph.D., about her research that found that potassium-rich foods cut the risk of stroke and death in older women. Dr. Smoller is distinguished university professor emerita of epidemiology & population health. (Monday, August 29, 2016)

More coverage on Dr. Wassertheil-Smoller | Dr. Wassertheil-Smoller's Profile


Crain’s Health Pulse interviews Dr. Laurie Bauman regarding a collaborative study aimed at controlling the spread of HIV using PrEP, a drug proven to reduce risk. Dr. Bauman is a principal investigator on the study, which includes Einstein, Montefiore and Columbia. She also is director of the Preventive Intervention Research Center and professor of pediatrics. (Friday, July 29, 2016)

More coverage on Dr. Bauman | Dr. Bauman's Profile

First Page | Previous Page | Page of 14 | Next Page | Last Page